Log In
Print
BCIQ
Print
Print this Print this
 

Piromelatine (Neu-P11)

  Manage Alerts
Collapse Summary General Information
Company Neurim Pharmaceuticals Ltd.
DescriptionMelatonin MT1 and MT2 receptor agonist and serotonin (5-HT1A) and 5-HT1D receptor agonist
Molecular Target Melatonin MT1 receptor ; Serotonin (5-HT1A) receptor
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationInsomnia
Indication DetailsTreat primary insomnia
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today